Intervention for High-normal or Borderline-elevated Blood Pressure in Adults With Type 2 Diabetes "IPAD"

Not yet recruiting

Phase 4 Results N/A

Summary of Purpose

Lowering of blood pressure (BP) in high-risk hypertensive individuals reduces major adverse cardiovascular (CV) events. Diabetic patients with hypertension benefit from BP lowering treatment. The present trial,IPAD in brief, is a randomized, double-blind, placebo-controlled, parallel-group, multicenter study involving 12,000 patients to be recruited over three years and to be followed up for a median of three...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 January 2018.

1 Feb 2018 21 Aug 2017 1 Sep 2022 1 Sep 2022 1 Jan 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts

  • Jiyan Chen, MD